Cotinga Pharmaceuticals Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Cotinga Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Cotinga Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Cotinga Pharmaceuticals is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 40.7 K | |
| Total Cashflows From Investing Activities | -12.7 K |
Cotinga |
Cotinga Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest (100.00) in Cotinga Pharmaceuticals on October 17, 2025 and sell it today you would earn a total of 100.00 from holding Cotinga Pharmaceuticals or generate -100.0% return on investment over 90 days. Cotinga Pharmaceuticals is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Cotinga, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Cotinga Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cotinga Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Cotinga Pharmaceuticals, and traders can use it to determine the average amount a Cotinga Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| COTQF |
Based on monthly moving average Cotinga Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cotinga Pharmaceuticals by adding Cotinga Pharmaceuticals to a well-diversified portfolio.
Cotinga Pharmaceuticals Fundamentals Growth
Cotinga Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Cotinga Pharmaceuticals, and Cotinga Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cotinga Pink Sheet performance.
| Return On Asset | -1.2 | |||
| Current Valuation | 333.25 K | |||
| Shares Outstanding | 21.99 M | |||
| Price To Earning | (2.81) X | |||
| Price To Book | 7.55 X | |||
| EBITDA | (2.44 M) | |||
| Cash And Equivalents | 46.11 K | |||
| Debt To Equity | 0.13 % | |||
| Book Value Per Share | (0.18) X | |||
| Cash Flow From Operations | (1.69 M) | |||
| Earnings Per Share | (0.09) X | |||
| Total Asset | 1.25 M | |||
| Current Asset | 3.87 M | |||
| Current Liabilities | 2.63 M | |||
Things to note about Cotinga Pharmaceuticals performance evaluation
Checking the ongoing alerts about Cotinga Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Cotinga Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cotinga Pharmaceuticals is not yet fully synchronised with the market data | |
| Cotinga Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Cotinga Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Cotinga Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Cotinga Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cotinga Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cotinga to invest in growth at high rates of return. When we think about Cotinga Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (2.7 M) with loss before overhead, payroll, taxes, and interest of (728.24 K). | |
| Cotinga Pharmaceuticals has accumulated about 46.11 K in cash with (1.69 M) of positive cash flow from operations. |
- Analyzing Cotinga Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cotinga Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Cotinga Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cotinga Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cotinga Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cotinga Pharmaceuticals' pink sheet. These opinions can provide insight into Cotinga Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Cotinga Pink Sheet
If you are still planning to invest in Cotinga Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cotinga Pharmaceuticals' history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |